Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- BALATRE P., MERLEN J., GRANDJEAN L. Les esters nitrés des polyalcools en thérapeutique cardiovasculaire. Presse Med. 1949 Nov 19;57(73):1067–1069. [PubMed] [Google Scholar]
- CESARMAN T. Serendipitia y angina de pecho; informe priliminar sobre un hallazgo terapeutico. Arch Inst Cardiol Mex. 1957 Sep-Oct;27(5):563–580. [PubMed] [Google Scholar]
- COLE S. L., KAYE H., GRIFFITH G. C. Assay of anti-anginal agents. I. A curve analysis with multiple control periods. Circulation. 1957 Mar;15(3):405–413. doi: 10.1161/01.cir.15.3.405. [DOI] [PubMed] [Google Scholar]
- COSSIO P. The treatment of angina pectoris and other muscular pain due to ischemia with iproniazid and isoniazid. Am Heart J. 1958 Jul;56(1):113–118. doi: 10.1016/0002-8703(58)90169-8. [DOI] [PubMed] [Google Scholar]
- FIFE R., HOWITT G., STEVENSON J. Trial of drugs for angina of effort: the oral use of pentaerythritol tetranitrate, including a comparison with aminophylline and dihydroxypropyltheophylline. Scott Med J. 1958 Jan;3(1):15–20. doi: 10.1177/003693305800300102. [DOI] [PubMed] [Google Scholar]
- GREINER T., GOLD H., CATTELL M., TRAVELL J., BAKST H., RINZLER S. H., BENJAMIN Z. H., WARSHAW L. J., BOBB A. L., KWIT N. T. A method for the evaluation of the effects of drugs on cardiac pain in patients with angina of effort; a study of khellin (visammin). Am J Med. 1950 Aug;9(2):143–155. doi: 10.1016/0002-9343(50)90017-9. [DOI] [PubMed] [Google Scholar]
- JANUARY L. E., LEWIS B. I., LUBIN R. I., WILD J. B. Rauwolfia serpentina in the treatment of angina pectoris. Circulation. 1956 Aug;14(2):227–232. doi: 10.1161/01.cir.14.2.227. [DOI] [PubMed] [Google Scholar]
- PERLMAN A. A study of the therapeutic action and toxicity of pentaerythritol tetranitrate. Angiology. 1952 Feb;3(1):16–19. doi: 10.1177/000331975200300102. [DOI] [PubMed] [Google Scholar]
- PLOTZ M. Pentaerythritol tetranitrate: a new drug for the treatment of coronary insufficiency. N Y State J Med. 1952 Aug 15;52(16):2012–2015. [PubMed] [Google Scholar]
- RISEMAN J. E., ALTMAN G. E., KORETSKY S. Nitroglycerin and other nitrites in the treatment of angina pectoris; comparison of six preparations and four routes of administration. Circulation. 1958 Jan;17(1):22–39. doi: 10.1161/01.cir.17.1.22. [DOI] [PubMed] [Google Scholar]
- ROSENBERG H. N., MICHELSON A. L. The use of pentaerythritol tetranitrate in chronic coronary insufficiency. Am J Med Sci. 1955 Sep;230(3):254–258. doi: 10.1097/00000441-195509000-00003. [DOI] [PubMed] [Google Scholar]
- RUSSEK H. I., ZOHMAN B. L., DORSET V. J. Objective evaluation of coronary vasodilator drugs. Am J Med Sci. 1955 Jan;229(1):46–54. doi: 10.1097/00000441-195501000-00008. [DOI] [PubMed] [Google Scholar]
- RUSSEK H. I., ZOHMAN B. L., DRUMM A. E., WEINGARTEN W., DORSET V. J. Long-acting coronary vasodilator drugs: metamine, paveril, nitroglyn and peritrate. Circulation. 1955 Aug;12(2):169–175. doi: 10.1161/01.cir.12.2.169. [DOI] [PubMed] [Google Scholar]
- SILBER E. N., KATZ L. N. Coronary dilators and angina: reappraisal. J Am Med Assoc. 1953 Nov 21;153(12):1075–1076. doi: 10.1001/jama.1953.02940290007003. [DOI] [PubMed] [Google Scholar]
- TALLEY R. W., BEARD O. W., DOHERTY J. F. Use of pentaerythritol tetranitrate (peritrate) in treatment of angina pectoris. Am Heart J. 1952 Dec;44(6):866–871. doi: 10.1016/0002-8703(52)90132-4. [DOI] [PubMed] [Google Scholar]
- WEITZMAN D. Penta-erythritol tetranitrate in treatment of angina. Br Med J. 1953 Dec 26;2(4851):1409–1412. doi: 10.1136/bmj.2.4851.1409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WINSOR T., HUMPHREYS P. Influence of pentaerythritol tetranitrate (peritrate) on acute and chronic coronary insufficiency. Angiology. 1952 Feb;3(1):1–15. doi: 10.1177/000331975200300101. [DOI] [PubMed] [Google Scholar]
- WINSOR T., SCOTT C. C. Further observations of cardiovascular effects of pentaerythritol tetranitrate in animals and man. Am Heart J. 1955 Mar;49(3):414–427. doi: 10.1016/0002-8703(55)90035-1. [DOI] [PubMed] [Google Scholar]